Skip to content

Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation

Fatigue in Multiple Sclerosis: Evaluated With 3 Tesla MRI and Transcranial Magnetic Stimulation

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00342381
Enrollment
120
Registered
2006-06-21
Start date
2006-06-30
Completion date
2007-12-31
Last updated
2007-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue, Multiple Sclerosis

Keywords

Motor fatigue, Cognitive fatigue

Brief summary

The purpose of this study is to investigate fatigue in patients with multiple sclerosis (MS) and to determine the correlation between the symptom and cerebral changes.

Detailed description

Only recruiting from: Department of Neurology, Aarhus University Hospital, Denmark

Interventions

Single dose 3,4 diaminopyridine

DRUGPlacebo

Single dose placebo treatment

Sponsors

The Danish Multiple Sclerosis Society
CollaboratorUNKNOWN
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Relapsing remitting-multiple sclerosis (RR-MS) according to Poser criteria * EDSS: max 3.5 * Right handed * Normal function of the right hand

Exclusion criteria

* Disease interfering with MS * Known dementia * Drug or alcohol abuse * Treatment with psychoactive drugs within one week before study entry * Major changes of medical treatment within 3 weeks before study entry * Attack within 4 weeks before study entry * Pregnancy * Conditions interfering with 3,4-diaminopyridine treatment * Conditions interfering with MRI * Conditions interfering with transcranial magnetic stimulation

Design outcomes

Primary

MeasureTime frame
Cortical atrophyat the time of MRI
Changes in normal appearing white matter and normal appearing gray matter (MRS-, MTI- and DTI- parameters)at the time of MRI
Subjective fatigue (FSS)Weeks
Maximal voluntary isometric contraction, central activation before and after exerciseat the time of investigation
Digit Symbol-Coding scoresWeeks
Intracortical inhibition/facilitation determined by transcranial magnetic stimulation (+/- 3,4-diaminopyridine)at the time of investigation

Secondary

MeasureTime frame
Rapid voluntary twitchesat the time of investigation
6 minute walk testat the time of investigation
9-hole peg testat the time of investigation
WAIS/WMS testsat the time of investigation
WHO-5 Questionnaireat the time of investigation
Major Depression Inventoryat the time of investigation
Lesion loadat the time of MRI
Whole brain atrophyat the time of MRI
Subjective fatigue (VAS)at the time of investigation
Subjective fatigue (MFI-20, Danish version)Weeks

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026